Does Corona Pandemic Affect the Epidemiological and Clinical Characteristics of Ischemic Stroke?
Main Article Content
Abstract
COVID-19 is caused by the novel SARS-CoV-2 that has disseminated in a global pandemic. During this pandemic, the healthcare seeking of stroke patients faces relentlessly critical challenges, as doctors continue to struggle in uncharted territory because of There are increasing concerns regarding the impact of imposed health care and social restrictions in response to the corona virus disease 2019 (COVID-19) pandemic on the management and care of patients with stroke
Several cohort studies suggest that COVID-19 itself may be a risk factor for developing a vascular event, while raising concerns about increased morbidity and morbidity.
Our objective is to determine the effect of the corona virus on the epidemiological and clinical characteristics of stroke patients.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Mouhamed Yazan Abou-Ismail, Akiva Diamond, Sargam Kapoor, Yasmin Arafah, and Lalitha Naya. The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management Thrombosis Research 194 (2020) 101–115).
II. an Xie, Benjamin Bowe, Geetha Maddukuri, Ziyad Al-Aly Comparative evaluation of clinical manifestations and risk of death in patients admitted to hospital with covid-19 and seasonal influenza: cohort study.
BMJ 2020; 371 doi: https://doi.org/10.1136/bmj.m4677).
III. Paliwal, P.R.; Tan, B.Y.Q.; Leow, A.S.T.; Sibi, S.; Chor, D.W.P.; Chin, A.X.Y.; Yau, Y.-W.; Cross, G.B.; Wong, L.Y.H.; Chia, M.L.J.; et al. Impact of the COVID-19 pandemic on hyperacute stroke treatment: Experience from a comprehensive stroke centre in Singapore. J. Thromb Thrombolysis 2020, 50, 596–603)
IV. Oxley TJ, Mocco J, Majidi S, Kellner CP, Shoirah H, Singh IP, De Leacy RA, Shigematsu T, Ladner TR, Yaeger KA, et al.. Large-vessel stroke as a presenting feature of COVID-19 in the young.N Engl J Med. 2020; 382:e60.
doi:10.1056/NEJMc2009787CrossrefMedlineGoogle Scholar
V. Sweid A, Hammoud B Bekelis K et al.Cerebral ischemic and hemorrhagic complications of coronavirus disease 2019. Int J Stroke. 2020.
https://doi.org/10.1177/1747493020937189).
VI. Wacharapluesadee S, Kaewpom T, Ampoot W, Ghai S, Khamhang W, Worachotsueptrakun K, Worachotsueptrakun K, Wanthong P, Nopvichai C, Supharatpariyakorn T, et al. Evaluating the efficiency of specimen pooling for PCR-based detection of COVID-19 .13, 2020. J Med Virol. doi: 10.1002/jmv.26005.
VII. Richard J Perry ,Craig J Smith ,Christine Roffe. Characteristics and outcomes of COVID-19 associated stroke: a UK multicentre case-control study . J Neurol Neurosurg Psychiatry (BMJ) 2021;92:242–248. doi:10.1136/jnnp-2020-324927)
VIII. Ford JS, Holmes JF, Jones RF. Cardioembolic stroke in a patient with coronavirus disease of 2019 (COVID-19) myocarditis: a case report. Clin Pract Cases Emerg Med 2020;4:332–5).
IX. Mohamud AY, Griffith B, Rehman M, et al. Intraluminal carotid artery thrombus in COVID-19: another danger of cytokine storm? AJNR Am J Neuroradiol 2020;41:1677–82.)
X. Yaghi S, Ishida K, Torres J, Mac Grory B, Raz E, Humbert K, Henninger N, Trivedi T, Lillemoe K, Alam S, et al. SARS-CoV-2 and stroke in a New York healthcare system. Stroke. 2020;51:2002–2011.
doi: 10.1161/STROKEAHA.120.030335)
XI. Fara MG, Stein LK, Skliut, M Morgello, S Fifi, JT Dhamoon MS. Macrothrombosis and stroke in patients with mild Covid-19 infection.J Thromb Haemost. 2020; (published online May 28.
https://doi.org/10.111/jth.14938)
XII. Perry R, Banaras A, Werring DJ, et al. What has caused the fall in stroke admissions during the COVID-19 pandemic? J Neurol 2020. doi:10.1007/s00415-020-10030-2. [Epub ahead of print: 29 Jun 2020]).
XIII. Aggarwal G, Lippi G, Michael Henry B. Cerebrovascular disease is associated with an increased disease severity in patients with coronavirus disease 2019 (COVID-19): a pooled analysis of published literature. Int J Stroke. 2020. doi: 10.1177/1747493020921664 ),